The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design
Open accessAbstract
Zika and dengue viruses belong to the Flavivirus genus, a close group of antigenically related viruses that cause significant arthropod-transmitted diseases throughout the globe. Although infection by a given flavivirus is thought to confer lifelong protection, some of the patient's antibodies cross-react with other flaviviruses without cross-neutralizing. The original antigenic sin phenomenon may amplify such antibodies upon subsequent heterologous flavivirus infection, potentially aggravating disease by antibody-dependent enhancement (ADE). The most striking example is provided by the four different dengue viruses, where infection by one serotype appears to predispose to more severe disease upon infection by a second one. A similar effect was postulated for sequential infections with Zika and dengue viruses. In this review, we analyze the molecular determinants of the dual antibody response to flavivirus infection or vaccination in humans. We highlight the role of conserved partially cryptic epitopes giving rise to cross-reacting and poorly neutralizing, ADE-prone antibodies. We end by proposing a strategy for developing an epitope-focused vaccine approach to avoid eliciting undesirable antibodies while focusing the immune system on producing protective antibodies only.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global distribution and burden of dengue
Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G., Sankoh, O., et al. (2013) · Nature · doi:10.1038/nature12060 · Cited by 10,037 · cited 1×
“Flaviviruses are a worldwide threat to public health, as exemplified by the global spread of dengue with an estimated 390 million annual infections [1], the explosive Zika virus epidemics across the Pacific, South and Central America since 2013 [2], and the inherent danger of urban yellow fever in Africa and South Ame…”
Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin
Skehel, J. J., & Wiley, D. C. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.531 · Cited by 2,706
Physical Principles in the Construction of Regular Viruses
Caspar, D. L. D., & Klug, A. (1962) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1962.027.001.005 · Cited by 2,522
The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus
Kraemer, M. U., Sinka, M. E., Duda, K. A., Mylne, A. Q., Shearer, F. M., Barker, C. M., Moore, C. G., Carvalho, R. G., Coelho, G. E., Van Bortel, W., et al. (2015) · eLife · doi:10.7554/elife.08347 · Cited by 2,160
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Kuhn, R. J., Zhang, W., Rossmann, M. G., Pletnev, S. V., Corver, J., Lenches, E., Jones, C. T., Mukhopadhyay, S., Chipman, P. R., Strauss, E. G., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00660-8 · Cited by 1,563
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C., & Harrison, S. C. (1995) · Nature · doi:10.1038/375291a0 · Cited by 1,437
Self-citationAntibody-dependent enhancement of severe dengue disease in humans
Katzelnick, L. C., Gresh, L., Halloran, M. E., Mercado, J. C., Kuan, G., Gordon, A., Balmaseda, A., & Harris, E. (2017) · Science · doi:10.1126/science.aan6836 · Cited by 1,205
Structure of the dengue virus envelope protein after membrane fusion
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2004) · Nature · doi:10.1038/nature02165 · Cited by 1,203
A ligand-binding pocket in the dengue virus envelope glycoprotein
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832193100 · Cited by 1,061
Capeding, M. R., Tran, N. H., Hadinegoro, S. R. S., Ismail, H. I. H. M., Chotpitayasunondh, T., Chua, M. N., Luong, C. Q., Rusmil, K., Wirawan, D. N., Nallusamy, R., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61060-6 · Cited by 973
Nucleotide Sequence of Yellow Fever Virus: Implications for Flavivirus Gene Expression and Evolution
Rice, C. M., Lenches, E. M., Eddy, S. R., Shin, S. J., Sheets, R. L., & Strauss, J. H. (1985) · Science · doi:10.1126/science.4023707 · Cited by 961
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Villar, L., Dayan, G. H., Arredondo-García, J. L., Rivera, D. M., Cunha, R., Deseda, C., Reynales, H., Costa, M. S., Morales-Ramírez, J. O., Carrasquilla, G., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411037 · Cited by 942
Dejnirattisai, W., Supasa, P., Wongwiwat, W., Rouvinski, A., Barba-Spaeth, G., Duangchinda, T., Sakuntabhai, A., Cao-Lormeau, V.-M., Malasit, P., Rey, F. A., et al. (2016) · Nature Immunology · doi:10.1038/ni.3515 · Cited by 914
Self-citationModified mRNA vaccines protect against zika virus infection
Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909
Fc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
Calisher, C. H., Karabatsos, N., Dalrymple, J. M., Shope, R. E., Porterfield, J. S., Westaway, E. G., & Brandt, W. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-37 · Cited by 893
Sabchareon, A., Wallace, D., Sirivichayakul, C., Limkittikul, K., Chanthavanich, P., Suvannadabba, S., Jiwariyavej, V., Dulyachai, W., Pengsaa, K., Wartel, T. A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61428-7 · Cited by 818
Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms
Rothman, A. L. (2011) · Nature Reviews Immunology · doi:10.1038/nri3014 · Cited by 770
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection
Stettler, K., Beltramello, M., Espinosa, D. A., Graham, V., Cassotta, A., Bianchi, S., Vanzetta, F., Minola, A., Jaconi, S., Mele, F., et al. (2016) · Science · doi:10.1126/science.aaf8505 · Cited by 758
Neutralization and Antibody-Dependent Enhancement of Dengue Viruses
Halstead, S. B. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)60011-4 · Cited by 739
Guzman, M. G., Alvarez, M., & Halstead, S. B. (2013) · Archives of Virology · doi:10.1007/s00705-013-1645-3 · Cited by 738
The 3.8 Å resolution cryo-EM structure of Zika virus
Sirohi, D., Chen, Z., Sun, L., Klose, T., Pierson, T. C., Rossmann, M. G., & Kuhn, R. J. (2016) · Science · doi:10.1126/science.aaf5316 · Cited by 738
RISK FACTORS IN DENGUE SHOCK SYNDROME: A PROSPECTIVE EPIDEMIOLOGIC STUDY IN RAYONG, THAILAND
SANGKAWIBHA, N., ROJANASUPHOT, S., AHANDRIK, S., VIRIYAPONGSE, S., JATANASEN, S., SALITUL, V., PHANTHUMACHINDA, B., & HALSTEAD, S. B. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113932 · Cited by 716
Harrison, S. C. (2015) · Virology · doi:10.1016/j.virol.2015.03.043 · Cited by 697
Zika virus: History, emergence, biology, and prospects for control
Weaver, S. C., Costa, F., Garcia-Blanco, M. A., Ko, A. I., Ribeiro, G. S., Saade, G., Shi, P.-Y., & Vasilakis, N. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.03.010 · Cited by 653
Structure of a flavivirus envelope glycoprotein in its low‐pH‐induced membrane fusion conformation
Bressanelli, S., Stiasny, K., Allison, S. L., Stura, E. A., Duquerroy, S., Lescar, J., Heinz, F. X., & Rey, F. A. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600064 · Cited by 593
Self-citationBeltramello, M., Williams, K. L., Simmons, C. P., Macagno, A., Simonelli, L., Quyen, N. T. H., Sukupolvi-Petty, S., Navarro-Sanchez, E., Young, P. R., de Silva, A. M., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.007 · Cited by 592
Self-citationEpidemic arboviral diseases: priorities for research and public health
Wilder-Smith, A., Gubler, D. J., Weaver, S. C., Monath, T. P., Heymann, D. L., & Scott, T. W. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30518-7 · Cited by 573
The Flavivirus Precursor Membrane-Envelope Protein Complex: Structure and Maturation
Li, L., Lok, S.-M., Yu, I.-M., Zhang, Y., Kuhn, R. J., Chen, J., & Rossmann, M. G. (2008) · Science · doi:10.1126/science.1153263 · Cited by 554
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
Bardina, S. V., Bunduc, P., Tripathi, S., Duehr, J., Frere, J. J., Brown, J. A., Nachbagauer, R., Foster, G. A., Krysztof, D., Tortorella, D., et al. (2017) · Science · doi:10.1126/science.aal4365 · Cited by 535
Structural basis of potent Zika–dengue virus antibody cross-neutralization
Barba-Spaeth, G., Dejnirattisai, W., Rouvinski, A., Vaney, M.-C., Medits, I., Sharma, A., Simon-Lorière, E., Sakuntabhai, A., Cao-Lormeau, V.-M., Haouz, A., et al. (2016) · Nature · doi:10.1038/nature18938 · Cited by 533
Self-citationDai, L., Song, J., Lu, X., Deng, Y.-Q., Musyoki, A. M., Cheng, H., Zhang, Y., Yuan, Y., Song, H., Haywood, J., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.04.013 · Cited by 502
Dejnirattisai, W., Wongwiwat, W., Supasa, S., Zhang, X., Dai, X., Rouvinski, A., Jumnainsong, A., Edwards, C., Quyen, N. T. H., Duangchinda, T., et al. (2015) · Nature Immunology · doi:10.1038/ni.3058 · Cited by 500
Self-citationStructures of immature flavivirus particles
Zhang, Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg270 · Cited by 499
Structure of the thermally stable Zika virus
Kostyuchenko, V. A., Lim, E. X. Y., Zhang, S., Fibriansah, G., Ng, T.-S., Ooi, J. S. G., Shi, J., & Lok, S.-M. (2016) · Nature · doi:10.1038/nature17994 · Cited by 487
THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION
Theiler, M., & Smith, H. H. (1937) · Journal of Experimental Medicine · doi:10.1084/jem.65.6.787 · Cited by 445
In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody
Halstead, S. B. (1979) · Journal of Infectious Diseases · doi:10.1093/infdis/140.4.527 · Cited by 438
Cryo-EM structure of the mature dengue virus at 3.5-Å resolution
Zhang, X., Ge, P., Yu, X., Brannan, J. M., Bi, G., Zhang, Q., Schein, S., & Zhou, Z. H. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2463 · Cited by 426
Structural Basis of Zika Virus-Specific Antibody Protection
Zhao, H., Fernandez, E., Dowd, K. A., Speer, S. D., Platt, D. J., Gorman, M. J., Govero, J., Nelson, C. A., Pierson, T. C., Diamond, M. S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.020 · Cited by 375
Westaway, E. G., Brinton, M. A., Gaidamovich, Y., Horzinek, M. C., Igarashi, A., Kääriäinen, L., Lvov, O. K., Porterfield, J. S., Russell, P. K., & Trent, D. W. (1985) · Intervirology · doi:10.1159/000149642 · Cited by 365
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
Lok, S.-M., Kostyuchenko, V., Nybakken, G. E., Holdaway, H. A., Battisti, A. J., Sukupolvi-Petty, S., Sedlak, D., Fremont, D. H., Chipman, P. R., Roehrig, J. T., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1382 · Cited by 354
Structural basis of West Nile virus neutralization by a therapeutic antibody
Nybakken, G. E., Oliphant, T., Johnson, S., Burke, S., Diamond, M. S., & Fremont, D. H. (2005) · Nature · doi:10.1038/nature03956 · Cited by 352
Receptors and routes of dengue virus entry into the host cells
Cruz-Oliveira, C., Freire, J. M., Conceição, T. M., Higa, L. M., Castanho, M. A. R. B., & Da Poian, A. T. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuu004 · Cited by 338
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico
Robbiani, D. F., Bozzacco, L., Keeffe, J. R., Khouri, R., Olsen, P. C., Gazumyan, A., Schaefer-Babajew, D., Avila-Rios, S., Nogueira, L., Patel, R., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.024 · Cited by 333
Lai, C.-Y., Tsai, W.-Y., Lin, S.-R., Kao, C.-L., Hu, H.-P., King, C.-C., Wu, H.-C., Chang, G.-J., & Wang, W.-K. (2008) · Journal of Virology · doi:10.1128/jvi.00316-08 · Cited by 326
The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection
Pierson, T. C., Xu, Q., Nelson, S., Oliphant, T., Nybakken, G. E., Fremont, D. H., & Diamond, M. S. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.03.002 · Cited by 308
Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH
Allison, S. L., Schalich, J., Stiasny, K., Mandl, C. W., Kunz, C., & Heinz, F. X. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.695-700.1995 · Cited by 305
Self-citationBroad-spectrum agents for flaviviral infections: dengue, Zika and beyond
Boldescu, V., Behnam, M. A. M., Vasilakis, N., & Klein, C. D. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.33 · Cited by 305
Hezareh, M., Hessell, A. J., Jensen, R. C., van de Winkel, J. G. J., & Parren, P. W. H. I. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12161-12168.2001 · Cited by 294
Dengue Virus Ensures Its Fusion in Late Endosomes Using Compartment-Specific Lipids
Zaitseva, E., Yang, S.-T., Melikov, K., Pourmal, S., & Chernomordik, L. V. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001131 · Cited by 287
Animal Models of Zika Virus Infection, Pathogenesis, and Immunity
Morrison, T. E., & Diamond, M. S. (2017) · Journal of Virology · doi:10.1128/jvi.00009-17 · Cited by 275
Degrees of maturity: the complex structure and biology of flaviviruses
Pierson, T. C., & Diamond, M. S. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.02.011 · Cited by 265
Dengue viruses cluster antigenically but not as discrete serotypes
Katzelnick, L. C., Fonville, J. M., Gromowski, G. D., Arriaga, J. B., Green, A., James, S. L., Lau, L., Montoya, M., Wang, C., VanBlargan, L. A., et al. (2015) · Science · doi:10.1126/science.aac5017 · Cited by 239
Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers
Fibriansah, G., Ibarra, K. D., Ng, T.-S., Smith, S. A., Tan, J. L., Lim, X.-N., Ooi, J. S. G., Kostyuchenko, V. A., Wang, J., de Silva, A. M., et al. (2015) · Science · doi:10.1126/science.aaa8651 · Cited by 230
Dengue structure differs at the temperatures of its human and mosquito hosts
Zhang, X., Sheng, J., Plevka, P., Kuhn, R. J., Diamond, M. S., & Rossmann, M. G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304300110 · Cited by 227
The Structural Basis for Serotype-Specific Neutralization of Dengue Virus by a Human Antibody
Teoh, E. P., Kukkaro, P., Teo, E. W., Lim, A. P. C., Tan, T. T., Yip, A., Schul, W., Aung, M., Kostyuchenko, V. A., Leo, Y. S., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003888 · Cited by 216
Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody
Cherrier, M. V., Kaufmann, B., Nybakken, G. E., Lok, S., Warren, J. T., Chen, B. R., Nelson, C. A., Kostyuchenko, V. A., Holdaway, H. A., Chipman, P. R., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.245 · Cited by 213
Antibody-Dependent Enhancement of Viral Infectivity
Porterfield, J. S. (1986) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60268-7 · Cited by 202
Fibriansah, G., Tan, J. L., Smith, S. A., de Alwis, R., Ng, T.-S., Kostyuchenko, V. A., Jadi, R. S., Kukkaro, P., de Silva, A. M., Crowe, J. E., et al. (2015) · Nature Communications · doi:10.1038/ncomms7341 · Cited by 202
Katzelnick, L. C., Montoya, M., Gresh, L., Balmaseda, A., & Harris, E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522136113 · Cited by 195
Structural Changes in Dengue Virus When Exposed to a Temperature of 37°C
Fibriansah, G., Ng, T.-S., Kostyuchenko, V. A., Lee, J., Lee, S., Wang, J., & Lok, S.-M. (2013) · Journal of Virology · doi:10.1128/jvi.00757-13 · Cited by 194
de Alwis, R., Williams, K. L., Schmid, M. A., Lai, C.-Y., Patel, B., Smith, S. A., Crowe, J. E., Wang, W.-K., Harris, E., & de Silva, A. M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004386 · Cited by 194
Heinz, F. X., & Stiasny, K. (2017) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00055-16 · Cited by 192
Self-citationAntibody-mediated neutralization of flaviviruses: A reductionist view
Dowd, K. A., & Pierson, T. C. (2011) · Virology · doi:10.1016/j.virol.2010.12.020 · Cited by 186
Deng, Y., Dai, J., Ji, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016059 · Cited by 176
Properties and Functions of the Dengue Virus Capsid Protein
Byk, L. A., & Gamarnik, A. V. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042334 · Cited by 175
Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus
Oliphant, T., Nybakken, G. E., Austin, S. K., Xu, Q., Bramson, J., Loeb, M., Throsby, M., Fremont, D. H., Pierson, T. C., & Diamond, M. S. (2007) · Journal of Virology · doi:10.1128/jvi.00643-07 · Cited by 171
Libraty, D. H., Acosta, L. P., Tallo, V., Segubre-Mercado, E., Bautista, A., Potts, J. A., Jarman, R. G., Yoon, I.-K., Gibbons, R. V., Brion, J. D., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000171 · Cited by 171
Fibriansah, G., Tan, J. L., Smith, S. A., de Alwis, A. R., Ng, T., Kostyuchenko, V. A., Ibarra, K. D., Wang, J., Harris, E., de Silva, A., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303404 · Cited by 169
Garten, W., Hallenberger, S., Ortmann, D., Schäfer, W., Vey, M., Angliker, H., Shaw, E., & Klenk, H. D. (1994) · Biochimie · doi:10.1016/0300-9084(94)90149-x · Cited by 167
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
Pierson, T. C., & Diamond, M. S. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000665 · Cited by 166
Wang, X., Li, S.-H., Zhu, L., Nian, Q.-G., Yuan, S., Gao, Q., Hu, Z., Ye, Q., Li, X.-F., Xie, D.-Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00024-6 · Cited by 162
Smith, S. A., Zhou, Y., Olivarez, N. P., Broadwater, A. H., de Silva, A. M., & Crowe, J. E. (2012) · Journal of Virology · doi:10.1128/jvi.06335-11 · Cited by 161
A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential
Wang, J., Bardelli, M., Espinosa, D. A., Pedotti, M., Ng, T., Bianchi, S., Simonelli, L., Lim, E. X. Y., Foglierini, M., Zatta, F., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.002 · Cited by 157
Wines, B. D., Powell, M. S., Parren, P. W. H. I., Barnes, N. C., & Hogarth, P. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5313 · Cited by 152
A new mechanism for the neutralization of enveloped viruses by antiviral antibody
Gollins, S., & Porterfield, J. S. (1986) · Nature · doi:10.1038/321244a0 · Cited by 152
Immature and Mature Dengue Serotype 1 Virus Structures Provide Insight into the Maturation Process
Kostyuchenko, V. A., Zhang, Q., Tan, J. L., Ng, T., & Lok, S. (2013) · Journal of Virology · doi:10.1128/jvi.00197-13 · Cited by 151
Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques
George, J., Valiant, W. G., Mattapallil, M. J., Walker, M., Huang, Y. S., Vanlandingham, D. L., Misamore, J., Greenhouse, J. J., Weiss, D. E., Verthelyi, D. I., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10901-1 · Cited by 150
Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection
Chan, K. R., Zhang, S. L.-X., Tan, H. C., Chan, Y., Chow, A. Y., Lim, A. P. C., Vasudevan, S. G., Hanson, B. J., & Ooi, E. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106568108 · Cited by 148
Bhardwaj, S., Holbrook, M. R., Shope, R. E., Barrett, A. D. T., & Watowich, S. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.8.4002-4007.2001 · Cited by 145
A human antibody against Zika virus crosslinks the E protein to prevent infection
Hasan, S. S., Miller, A. S., Sapparapu, G., Fernández, E., Klose, T., Long, F., Fokine, A., Porta, J. C., Jiang, W., Diamond, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms14722 · Cited by 144
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques
McCracken, M. K., Gromowski, G. D., Friberg, H., Lin, X., Abbink, P., Barrera, R. A. D. L., Eckles, K. H., Garver, L. S., Boyd, M. B., Jetton, D., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006487 · Cited by 144
Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day
Collins, N. D., & Barrett, A. D. T. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0566-9 · Cited by 141
Membrane Interactions of the Tick-Borne Encephalitis Virus Fusion Protein E at Low pH
Stiasny, K., Allison, S. L., Schalich, J., & Heinz, F. X. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3784-3790.2002 · Cited by 140
Self-citationRevisiting Dengue Virus–Host Cell Interaction
Acosta, E. G., Kumar, A., & Bartenschlager, R. F. W. (2014) · Advances in virus research · doi:10.1016/b978-0-12-800098-4.00001-5 · Cited by 139
Yang, M., Lai, H., Sun, H., & Chen, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-08247-9 · Cited by 138
Corver, J., Ortiz, A., Allison, S. L., Schalich, J., Heinz, F. X., & Wilschut, J. (2000) · Virology · doi:10.1006/viro.1999.0172 · Cited by 137
Self-citationMechanism of Dengue Virus Broad Cross-Neutralization by a Monoclonal Antibody
Cockburn, J. J. B., Sanchez, M. E. N., Fretes, N., Urvoas, A., Staropoli, I., Kikuti, C. M., Coffey, L. L., Arenzana‐Seisdedos, F., Bedouelle, H., & Rey, F. A. (2012) · Structure · doi:10.1016/j.str.2012.01.001 · Cited by 137
Self-citationThe many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design
Watterson, D., Modhiran, N., & Young, P. R. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.02.014 · Cited by 135
Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres
Plevka, P., Battisti, A. J., Junjhon, J., Winkler, D. C., Holdaway, H. A., Keelapang, P., Sittisombut, N., Kuhn, R. J., Steven, A. C., & Rossmann, M. G. (2011) · EMBO Reports · doi:10.1038/embor.2011.75 · Cited by 132
West Nile Virus in the United States — A Historical Perspective
Roehrig, J. T. (2013) · Viruses · doi:10.3390/v5123088 · Cited by 131
West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody
Kaufmann, B., Nybakken, G. E., Chipman, P. R., Zhang, W., Diamond, M., Fremont, D. H., Kuhn, R. J., & Rossmann, M. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603488103 · Cited by 128
Kaufmann, B., Vogt, M. R., Goudsmit, J., Holdaway, H. A., Aksyuk, A. A., Chipman, P. R., Kuhn, R. J., Diamond, M., & Rossmann, M. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011036107 · Cited by 128
Austin, S. K., Dowd, K. A., Shrestha, B., Nelson, C. A., Edeling, M. A., Johnson, S., Pierson, T. C., Diamond, M., & Fremont, D. H. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002930 · Cited by 121
Fernández, E., Dejnirattisai, W., Cao, B., Scheaffer, S. M., Supasa, P., Wongwiwat, W., Esakky, P., Drury, A. M., Mongkolsapaya, J., Moley, K. H., et al. (2017) · Nature Immunology · doi:10.1038/ni.3849 · Cited by 121
VanBlargan, L. A., Goo, L., & Pierson, T. C. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00024-15 · Cited by 118
Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology
Priyamvada, L., Hudson, W. H., Ahmed, R., & Wrammert, J. (2017) · Emerging Microbes & Infections · doi:10.1038/emi.2017.42 · Cited by 114
Kuhn, R. J., Dowd, K. A., Post, C. B., & Pierson, T. C. (2015) · Virology · doi:10.1016/j.virol.2015.03.025 · Cited by 111
Neutralization mechanism of a highly potent antibody against Zika virus
Zhang, S., Kostyuchenko, V. A., Ng, T., Lim, X.-N., Ooi, J. S. G., Lambert, S., Tan, T. Y., Widman, D. G., Shi, J. R., Baric, R. S., et al. (2016) · Nature Communications · doi:10.1038/ncomms13679 · Cited by 106
Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity
Chan, K. R., Wang, X., Saron, W. A. A., Gan, E. S., Tan, H. C., Mok, D. Z. L., Zhang, S. L.-X., Lee, Y. H., Liang, C., Wijaya, L., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.164 · Cited by 105
A Model for Neutralization of Viruses Based on Antibody Coating of the Virion Surface
Burton, D. R., Saphire, E. O., & Parren, P. W. H. I. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05783-4_7 · Cited by 104
Rouvinski, A., Dejnirattisai, W., Guardado‐Calvo, P., Vaney, M. C., Sharma, A., Duquerroy, S., Supasa, P., Wongwiwat, W., Haouz, A., Spaeth, G. B., et al. (2017) · Nature Communications · doi:10.1038/ncomms15411 · Cited by 104
Self-citationNg, J. K. W., Zhang, S. L.-X., Tan, H. C., Yan, B., Gómez, J. M. M., Tan, W. Y., Lam, J. H., Tan, G. K. X., Ooi, E. E., & Alonso, S. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004031 · Cited by 103
Smith, S. A., de Alwis, A. R., Kose, N., Jadi, R., de Silva, A. M., & Crowe, J. E. (2014) · Journal of Virology · doi:10.1128/jvi.00247-14 · Cited by 99
Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors
Rogers, T. F., Goodwin, E. C., Briney, B. S., Sok, D., Beutler, N., Strubel, A., Nedellec, R., Le, K. M., Brown, M. E., Burton, D. R., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan6809 · Cited by 97
Immune correlates of protection for dengue: State of the art and research agenda
Katzelnick, L. C., Harris, E., Baric, R. S., Coller, B.-A., Coloma, J., Crowe, J. E., Cummings, D. A. T., Dean, H. J., de Silva, A., Diamond, M. S., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.045 · Cited by 95
Self-citationGoo, L., VanBlargan, L. A., Dowd, K. A., Diamond, M., & Pierson, T. C. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006178 · Cited by 93
Cockburn, J. J. B., Sanchez, M. E. N., Goncalvez, A. P., Zaitseva, E., Stura, E. A., Kikuti, C. M., Duquerroy, S., Dussart, P., Chernomordik, L., Lai, C., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.439 · Cited by 92
Self-citationNear-Atomic Resolution Cryo-Electron Microscopic Structure of Dengue Serotype 4 Virus
Kostyuchenko, V. A., Chew, P. L., Ng, T., & Lok, S. (2013) · Journal of Virology · doi:10.1128/jvi.02641-13 · Cited by 92
Midgley, C. M., Flanagan, A., Tran, H. B., Dejnirattisai, W., Chawansuntati, K., Jumnainsong, A., Wongwiwat, W., Duangchinda, T., Mongkolsapaya, J., Grimes, J. M., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200227 · Cited by 90
Williams, K. L., Sukupolvi-Petty, S., Beltramello, M., Johnson, S., Sallusto, F., Lanzavecchia, A., Diamond, M., & Harris, E. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003157 · Cited by 85
Dowd, K. A., DeMaso, C. R., & Pierson, T. C. (2015) · mBio · doi:10.1128/mbio.01559-15 · Cited by 85
Williams, K. L., Wahala, W. M. P. B., Orozco, S. L., de Silva, A. M., & Harris, E. (2012) · Virology · doi:10.1016/j.virol.2012.03.003 · Cited by 83
Enhancing dengue virus maturation using a stable furin over-expressing cell line
Mukherjee, S., Sirohi, D., Dowd, K. A., Chen, Z., Diamond, M. S., Kuhn, R. J., & Pierson, T. C. (2016) · Virology · doi:10.1016/j.virol.2016.06.022 · Cited by 82
A recombinant live attenuated tetravalent vaccine for the prevention of dengue
Guy, B., Noriega, F. R., Ochiai, R. L., L’Azou, M., Delore, V., Skipetrova, A., Verdier, F., Coudeville, L., Savarino, S. J., & Jackson, N. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1335201 · Cited by 79
A novel mechanism of antibody-mediated enhancement of flavivirus infection
Haslwanter, D., Blaas, D., Heinz, F. X., & Stiasny, K. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006643 · Cited by 73
Self-citationThe development of therapeutic antibodies against dengue virus
Fibriansah, G., & Lok, S. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.01.002 · Cited by 62
The Interplay of Dengue Virus Morphological Diversity and Human Antibodies
Lok, S. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.12.004 · Cited by 61
Smith, S. A., Nivarthi, U. K., de Alwis, R., Kose, N., Sapparapu, G., Bombardi, R. G., Kahle, K. M., Pfaff, J. M., Lieberman, S., Doranz, B. J., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01805-15 · Cited by 58
The Etiology of Yellow Fever???A Preliminary Note
Reed, R., Cakroll, AGBAMONTE, & Lazear (1901) · The American Journal of the Medical Sciences · doi:10.1097/00000441-190102000-00019 · Cited by 57
The Etiology of Yellow Fever: A Preliminary Note
Reed, W., Carroll, J., Agramonte, A., et al. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.6.1103 · Cited by 54
Plotkin, S. A., Orenstein, W. A., & Offit, P. A. (2017) · Elsevier eBooks · doi:10.1016/c2013-0-18914-3 · Cited by 54
Poggianella, M., Slon-Campos, J., Chan, K. R., Tan, H. C., Bestagno, M., Ooi, E. E., & Burrone, Ó. R. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003947 · Cited by 52
Molecular basis of antibody‐mediated neutralization and protection against flavivirus
Dai, L., Wang, Q., Qi, J., Shi, Y., Yan, J., & Gao, G. F. (2016) · IUBMB Life · doi:10.1002/iub.1556 · Cited by 51
Pierson, T. C., & Diamond, M. (2014) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.10.005 · Cited by 48
de Silva, & Harris, E. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a029371 · Cited by 43
Acosta, E. G., & Bartenschlager, R. F. W. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1121814 · Cited by 42
The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis
Gan, E. S., Ting, D. H. R., & Chan, K. R. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1254550 · Cited by 42
The Etiology of Yellow Fever — A Preliminary Note
Reed, W., Carroll, J., Agramonte, A., & Lazear, J. W. (2001) · Military Medicine · doi:10.1093/milmed/166.suppl_1.29 · Cited by 40
Tsouchnikas, G., Zlatkovic, J., Jarmer, J., Strauß, J., Vratskikh, O., Kundi, M., Stiasny, K., & Heinz, F. X. (2015) · Journal of Virology · doi:10.1128/jvi.00938-15 · Cited by 26
Self-citationSnapShot: Viral and Eukaryotic Protein Fusogens
Igonet, S., & Rey, F. A. (2012) · Cell · doi:10.1016/j.cell.2012.11.041 · Cited by 20
Self-citationDengue-specific subviral nanoparticles: design, creation and characterization
Khetarpal, N., Poddar, A., Nemani, S. K., Dhar, N., Patil, A. V., Negi, P., Perween, A., Viswanathan, R., Lünsdorf, H., Tyagi, P., et al. (2013) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-11-15 · Cited by 10
Cited by
The continued threat of emerging flaviviruses
Pierson, T. C., & Diamond, M. S. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0714-0 · Cited by 1,098
Viral targets for vaccines against COVID-19
Dai, L., & Gao, G. F. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00480-0 · Cited by 1,048
Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants
Qu, L., Yi, Z., Shen, Y., Lin, L., Chen, F., Xu, Y., Wu, Z., Tang, H., Zhang, X., Tian, F., et al. (2021) · doi:10.1101/2021.03.16.435594 · Cited by 636
Virus–Receptor Interactions: The Key to Cellular Invasion
Maginnis, M. S. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.024 · Cited by 413
Adaptive immune responses to primary and secondary dengue virus infections
St. John, A. L., & Rathore, A. P. S. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0123-x · Cited by 327
Metadata
- Authors
- Rey, F. A., Stiasny, K., Vaney, M., Dellarole, M., & Heinz, F. X.
- Venue
- EMBO reports
- Published
- 2017-12-27
- Volume
- 19
- Issue
- 2
- Pages
- 206-224
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- OpenAlex
- W2777057590
- Cited by
- 259
- References
- 134
- FWCI
- 23.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.